AXGN

AxoGen Inc

$46.18

1.47 (3.29%) Today

0.01 (0.02%) After-hours

— up— down

Compare AXGN

Market Cap

$2.38B+325.7%

Revenue (TTM)

$245.44M+22.4%

Net Income (TTM)

$-33,827,798

EPS (TTM)

-0.64

Shares Out

53.18M

Forward P/E

70.57

Open

$44.61

Previous Close

$44.72

Day Range

$43.33 – $46.26

52-Week Range

$10.58 – $46.26

Beta

1.10

Volume

1.20M

Avg Volume

1.12M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About AXGN

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.